Chinese pharma companies have surely made some progresses in innovation during the past few years, among which over 800 companies already have Class 1 innovative projects
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 16 of 58
The chart uses a broken y-axis to accommodate the large number of companies in the 1-5 project range.
Consulting deck · market_landscape · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 disclaimer 1/1 legend 1/1 title 2/2
Components 5
bar-stacked disclaimer legend action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.